Global Hospital acquired disease testing market report

Health 539 views 0 0

Analysts of Technavio forecasted and prepared a report on the global hospital-acquired disease testing market that it is supposed to grow at a CAGR of 19.44% over the period 2014-2019.

Technavio‘s analysts have prepared this report on the basis of an in-depth market analysis with inputs from industry experts. The report covers the landscape of the global hospital-acquired disease testing market and its growth prospects in the coming years. The report also includes a discussion of key vendors operating in this market.

The key regions which this report involves are America, APAC and EMEA. Abbott Laboratories, Becton and Dickenson, bioMerieux and Roche Diagnostics are the key vendors who have been included in this report.

According to this report, the major challenge in the market involves lack of healthcare Infrastructure, which proves no less than a hindrance while implementing the suitable health policies among the masses.

Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA and gastrointestinal illnesses. These infections appear between 48 hours and four days after a patient is admitted and are usually related to a treatment of procedure used to treat or diagnose the patient’s initial illness or injury.

Hospital-acquired diseases are preventable through adherence to strict guidelines and less usage of invasive equipment that must be followed by healthcare professionals while caring for the patient.


Global Hospitals Group, is India’s most renowned healthcare services provider offering better care, cutting-edge research and advanced education to care givers, is one of the country’s fast growing chains of Multi Super Specialty Tertiary Care Hospitals offering healthcare services of international standards. A 2000-bed Multi Super Specialty Tertiary Care facility spread across Hyderabad, Chennai, Bangalore and Mumbai, Global Hospitals is a pioneer in Multi-Organ Transplants including kidneys, liver, heart and lung.

Sharing is caring!


0 thoughts on “Global Hospital acquired disease testing market report”

Leave a Reply

Your email address will not be published. Required fields are marked *